Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity

Detection Principle
IgA, IgM, IgG
Testing Method Category
Testing Method
kit (NovaTec)
Testing Method - Additional Info
Novalisa NovaTec Immunodiagnostica, Dietzenbach, Germany
Reported Performance
diagnostic performances (AUC): 0.943 (IgA), 0.856 (IgM), 0.934 (IgG); Sensitivity: 69% (IgA, 11 NTU), 80.6% (IgA, 6NTU), 48.8% (IgM, 11 NTU), 72.9% (IgM, 5 NTU), 79.8% (IgG, 11 NTU), 83.7% (IgG, 9 NTU); Specificity: 100% (IgA, 11 Novatec Threshould Units), 97.6% (IgA, 6NTU), 97.6% (IgM, 11 NTU), 88% (IgM, 5 NTU), 100% (IgG, 11 NTU), 97.6% (IgG, 9 NTU)
Sample Size
171 samples

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements